STUDY OF PHOTOSENSITIZER FOR ANTIBACTERIAL PHOTODYNAMIC THERAPY BASED ON CYCLODEXTRIN FORMULATION OF 133-N-(N-METHYLNICOTINYL)BACTERIOPURPURINIMIDE METHYL ESTER
| Autor: | Meerovich, G. A., Akhlyustina, E. V., Tiganova, I. G., Panov, V. A., Tyukova, V. S., Tolordava, E. R., Alekseeva, N. V., Linkov, K. G., Romanova, Yu M., Grin, M. A., Andrey F. Mironov, Loshchenov, V. B., Kaprin, A. D., Filonenko, E. V. |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
030103 biophysics Biodistribution метиловый эфир 133-N-(N-метилникотинил)бактериопурпуринимида циклодекстрин lcsh:Medical technology medicine.medical_treatment Photodynamic therapy antibacterial photodynamic therapy Dermatology Absorption (skin) антимикробная фотодинамическая терапия 03 medical and health sciences Pharmacokinetics производные бактериохлорина In vivo Medical technology medicine Photosensitizer R855-855.5 chemistry.chemical_classification Chromatography Cyclodextrin aggregation флуоресценция bacteriochlorine derivative 133-N-(N-methylnicotinyl)-bacteriopurpurinimide methyl ester Fluorescence cyclodextrin chemistry lcsh:R855-855.5 агрегация Surgery поглощение fluorescence absorption |
| Zdroj: | Biomedical Photonics, Vol 6, Iss 3, Pp 16-32 (2017) Scopus-Elsevier ResearcherID |
| ISSN: | 2413-9432 |
| Popis: | Cationic bacteriochlorins are promising as antibacterial photosensitizers (PS) for antibacterial photodynamic therapy. Current work is devoted to the study of properties of new nanostructured cationic photosensitizer based on cyclodextrin dispersion of bacteriochlorine derivative – 133-N-(N-methylnicotinyl)-bacteriopurpurinimide methyl ester, for optimization of dispersion composition and selection of time interval between administration of the PS and photodynamic ttherapy of infected septic wounds. Specifics of absorption and fluorescence of PS in dependence of its concentration and proportions of components in dispersion was assessed. Pharmacokinetics and biodistribution of PS were studies in vivo in organs and tissues of intact mice and septic wounds infected with P. аeruginosa or S. aureus. The preliminary studies have shown high efficiency of antimicrobial photodynamic therapy of septic wounds with cyclodextrin dispersion of 133-N-(N-methylnicotinyl)-bacteriopurpurinimide methyl ester. Results of study of absorption and spectral and fluorescence properties of its drug formulation depending on its composition allowed to recommend the use of weight ratio 133-N-(N-methylnicotinyl)bacteriopurpurinimide methyl ester : cyclodextrin about 1:200 and addition of 0,1% Tween 80 to reduce aggregation. The study showed that 133-N-(N-methylnicotinyl)-bacteriopurpurinimide methyl ester was rapidly cleared from mouse blood circulation: more than 70% – for 2 h, 95% – for 1 day, more than 99% – for 6 days. About 98% was cleared from skin and muscles for 6 days. The long-term (up to 24 h) persistence of PS were observed in liver and kidneys, however more than 99% was cleared for 6 days. Thus, it may be supposed that elimination of PS form mice body is through kidneys and liver. After 24 h partial PS aggregation in tissues, particularly in skin and muscles, was observed. Thus, it may be supposed that the reduce of fluorescence intensity after 24 hand later was associated not only with its elimination from body but with its aggregation. Spectral and fluorescence studies showed that 133-N-(Nmethylnicotinyl)-bacteriopurpurinimide methyl ester selectively accumulated in septic wounds, fluorescence contrast was in the range of 3–4. The highest values of concentration and selectivity of its accumulation were achieved at 1.5–3 h after intravenous injection. The irradiation 2 h after injection provided high efficacy of the therapy of septic wounds. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|